Our Products

Capecitabine Tablets USP 150 mg is an oral chemotherapy medication used primarily in the treatment of various types of cancer, including breast cancer, colorectal cancer, and gastric cancer. It is a prodrug that is converted into its active form, 5-fluorouracil (5-FU), in the body. 5-FU inhibits the growth of cancer cells by interfering with their DNA synthesis, thereby preventing their replication and spread.

The 150 mg dosage is typically taken twice daily with food, often as part of a treatment cycle, and the dosage may be adjusted based on the patient’s condition and tolerance. Common side effects of Capecitabine include nausea, diarrhea, hand-foot syndrome (pain and redness on the palms and soles), fatigue, and low blood cell counts. Close monitoring by a healthcare provider is essential during treatment to manage potential side effects and adjust dosages accordingly.